Sort
21,453 grants matching “tuberculosis”
Immuno-Chemotherapy to Shorten TB Treatment
$300,000Rhea N Coler · Pai Life Sciences, Inc. · R43 · FY2015 · AI
South Africa Tuberculosis AIDS Training (SATBAT)
$300,000Neil A Martinson · Wits Health Consortium (Pty), Ltd · U2R · FY2011 · TW
Development of an ELISA for serosurveillance of human hookworm
$300,000Andrew E. Levin · Kephera Diagnostics, Llc · R43 · FY2023 · AI
The Ligase and Acetyltransferase Enzymes of Mycothiol Biosynthesis
$300,000Robert C Fahey · University Of California-San Diego · · FY2000 · BIO
Facile Detection of Soil-Transmitted Helminth Infections
$300,000Michael J Crawford · Monsanto Company · R43 · FY2011 · AI
TRAINING PROGRAM IN TB AND HIV PREVENTION AND TREATMENT
$300,000New York University School Of Medicine · D43 · FY2001 · TW
Flow Direct: Next Generation Urine LFA for TB Diagnosis in Point-of-Care Settings
$300,000Jay Wyatt Warrick · Salus Discovery, Llc · R44 · FY2024 · AI
Belarus TB Database and TB Portal
$300,000National Institute Of Allergy And Infectious Diseases · Y01 · FY2014 · AI
Heterocyclic Inhibitors of QcrB as Novel Drugs for Tuberculosis
$300,000Thomas Joseph Hannan · Fimbrion Therapeutics, Inc. · R43 · FY2020 · AI
Control of Immune responses by lipoxins during tuberculosis
$300,000Julio Aliberti · Cincinnati Childrens Hosp Med Ctr · R01 · FY2008 · AI
Natural product-inspired antibacterials with unique ribosomal binding
$300,000Charles Testa · Curza Inc · R43 · FY2016 · AI
Cough collection as a replacement for sputum samples for diagnosing Tuberculosis
$300,000Patrick Sislian · Deton Corporation · R43 · FY2012 · AI
Tulane National Primate Research Center
$300,000Benjamin Paul Sachs · Tulane University Of Louisiana · P51 · FY2010 · RR
Targeting MtrAB of M. tuberculosis
$300,000Marina N Protopopova · Sequella, Inc. · R41 · FY2011 · AI
Integrated Microfluidic Platform for Point-of-Care Serodiagnostics
$300,000Xiaowu Liang · Immport Therapeutics, Inc. · R43 · FY2012 · AI
GENETIC DISSECTION OF MYCOBACTERIAL INFECTION
$300,000Mcgill University · R01 · FY2001 · HL
Biological Information Technology Systems - BITS: Modeling and Analysis of Biological and Information Networks
$300,000Harvey Rubin · University Of Pennsylvania · · FY2002 · CSE
A novel live intranasal TB vaccine
$300,000Frederick D Quinn · Pathens, Inc. · R41 · FY2013 · AI
International Training in AIDS/TB Prevention Research
$300,000Vinayaka R Prasad · Albert Einstein College Of Medicine · D43 · FY2011 · TW
Integrated Microfluidic Platform for Point-of-Care Serodiagnostics
$300,000Xiaowu Liang · Immport Therapeutics, Inc. · R43 · FY2013 · AI
Thiazolino-Pyridone Compounds as Novel Drugs for Tuberculosis
$300,000Thomas Joseph Hannan · Fimbrion Therapeutics, Inc. · R43 · FY2024 · AI
The development of a novel antifungal for drug resistance
$300,000Esteban Edward Mena · Lifepharms, Inc. · R43 · FY2025 · AI
DEVELOPMENT OF A HIGH THROUGHPUT MOLECULAR TOOL FOR STRAIN IDENTIFICATION AND RESISTANCE PROFILING OF MYCOBACTERIUM TUBERCULOSIS
$300,000Genome Institute Of Singapore · · FY2009 · Department of the Navy
Thiazolino-Pyridone Compounds as Novel Antimycobacterial Drugs for Tuberculosis
$300,000Nicholas Jentsch · Fimbrion Therapeutics, Inc. · R43 · FY2025 · AI
Development of a Cytokine Release Assay as a Diagnostic Test for Lyme Disease
$300,000Paul Michael Arnaboldi · Biopeptides, Inc. · R43 · FY2013 · AI